VETOQUINOL SA (VETO.PA) Stock Price & Overview
EPA:VETO • FR0004186856
Current stock price
The current stock price of VETO.PA is 78.4 EUR. Today VETO.PA is up by 0.13%. In the past month the price decreased by -4.62%. In the past year, price increased by 3.02%.
VETO.PA Key Statistics
- Market Cap
- 931.392M
- P/E
- 15.56
- Fwd P/E
- 14.36
- EPS (TTM)
- 5.04
- Dividend Yield
- 1.14%
VETO.PA Stock Performance
VETO.PA Stock Chart
VETO.PA Technical Analysis
ChartMill assigns a technical rating of 0 / 10 to VETO.PA. When comparing the yearly performance of all stocks, VETO.PA is a bad performer in the overall market: 74.97% of all stocks are doing better.
VETO.PA Fundamental Analysis
ChartMill assigns a fundamental rating of 6 / 10 to VETO.PA. VETO.PA is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average.
VETO.PA Earnings
VETO.PA Forecast & Estimates
11 analysts have analysed VETO.PA and the average price target is 95.12 EUR. This implies a price increase of 21.32% is expected in the next year compared to the current price of 78.4.
For the next year, analysts expect an EPS growth of 0.21% and a revenue growth -1.84% for VETO.PA
VETO.PA Groups
Sector & Classification
VETO.PA Financial Highlights
Over the last trailing twelve months VETO.PA reported a non-GAAP Earnings per Share(EPS) of 5.04. The EPS increased by 26.53% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 11.28% | ||
| ROA | 8.28% | ||
| ROE | 10.59% | ||
| Debt/Equity | 0.02 |
VETO.PA Ownership
VETO.PA Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| 1SAN | SANOFI | 9.77 | 100.393B | ||
| SAN | SANOFI | 9.74 | 100.102B | ||
| SNW | SANOFI | 9.73 | 100.041B | ||
| UCB | UCB SA | 25.72 | 51.448B | ||
| UNC | UCB SA | 25.39 | 50.806B | ||
| 1MRK | MERCK KGAA | 13.21 | 48.348B | ||
| MRK | MERCK KGAA | 13.28 | 47.739B | ||
| 1BAYN | BAYER AG-REG | 8.59 | 39.493B | ||
| BAYN | BAYER AG-REG | 8.48 | 38.997B | ||
| IPN | IPSEN | 13.73 | 14.038B | ||
| REC | RECORDATI INDUSTRIA CHIMICA | 17.45 | 10.457B | ||
| TUB | FINANCIERE DE TUBIZE | N/A | 9.77B | ||
| VIRP | VIRBAC SA | 16.3 | 2.945B |
Related stock screener links
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the Euronext Paris Exchange | Find stocks with similar TA and Setup ratings on the EuroNext exchanges | Find stocks with similar Fundamental rating on the EuroNext exchanges | Find the competitors with the best technical ratings on the EuroNext exchanges | Find the competitors with the best fundamentals on the EuroNext exchanges | Find the competitors with the best valuation on the EuroNext exchanges | Find the competitors with the best dividend on the EuroNext exchanges | Find the competitors with the best analyst ratings on the EuroNext exchanges
About VETO.PA
Company Profile
Vétoquinol SA operates as a global animal health company. The company is headquartered in Lure, Bourgogne-Franche-Comte. The company went IPO on 2006-11-16. The Company’s product portfolio is divided between livestock, such as cattle and pigs, and companion animals, including dogs and cats. Vetoquinol SA’s offering includes anti-infectives, such as Marbocyl; anti- pain inflammatories, which comprise Tolfedine, intended for dogs and cats, and Tolfine for livestock, and cardiovascular and nephrology treatment, such as Prilium, an oral daily administration formula for dogs, among others. The firm markets over 700 products, in such countries as France, Austria, Canada, Italy, Poland, Spain and the Netherlands, among others. The company trades its products throughout Europe, North America, Africa, the Middle East and Pacific Asia. In April 2014, it acquired Bioniche's animal health business.
Company Info
IPO: 2006-11-16
VETOQUINOL SA
Sainte-Anne 34 rue du Chene, Bp 189, Lure Cedex
Lure BOURGOGNE-FRANCHE-COMTE FR
Employees: 2519
Phone: 33384625555
VETOQUINOL SA / VETO.PA FAQ
What does VETO do?
Vétoquinol SA operates as a global animal health company. The company is headquartered in Lure, Bourgogne-Franche-Comte. The company went IPO on 2006-11-16. The Company’s product portfolio is divided between livestock, such as cattle and pigs, and companion animals, including dogs and cats. Vetoquinol SA’s offering includes anti-infectives, such as Marbocyl; anti- pain inflammatories, which comprise Tolfedine, intended for dogs and cats, and Tolfine for livestock, and cardiovascular and nephrology treatment, such as Prilium, an oral daily administration formula for dogs, among others. The firm markets over 700 products, in such countries as France, Austria, Canada, Italy, Poland, Spain and the Netherlands, among others. The company trades its products throughout Europe, North America, Africa, the Middle East and Pacific Asia. In April 2014, it acquired Bioniche's animal health business.
What is the current price of VETO stock?
The current stock price of VETO.PA is 78.4 EUR. The price increased by 0.13% in the last trading session.
What is the dividend status of VETOQUINOL SA?
VETOQUINOL SA (VETO.PA) has a dividend yield of 1.14%. The yearly dividend amount is currently 0.85.
What is the ChartMill technical and fundamental rating of VETO stock?
VETO.PA has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 6 out of 10.
What is the Price/Earnings (PE) ratio of VETOQUINOL SA (VETO.PA)?
The PE ratio for VETOQUINOL SA (VETO.PA) is 15.56. This is based on the reported non-GAAP earnings per share of 5.04 and the current share price of 78.4 EUR.
What is the expected growth for VETO stock?
The Revenue of VETOQUINOL SA (VETO.PA) is expected to decline by -1.84% in the next year. Check the estimates tab for more information on the EPS, Sales, EBIT and EBITDA future analyst estimates.